| Issue Date | Title | Author(s) |
| 2013 | Colorimetric detection of senescence-associated β galactosidase | Itahana, K. ; Itahana, Y. ; Dimri, G.P. |
| 2013 | Colorimetric detection of senescence-associated β galactosidase. | Itahana, K. ; Itahana, Y. ; Dimri, G.P. |
| 2012 | Emerging roles of mitochondrial p53 and ARF | Itahana, Y. ; Itahana, K. |
| 2018 | Emerging roles of p53 family members in glucose metabolism | Itahana, Y ; Itahana, K |
| 2016 | Germline hemizygous deletion of CDKN2A-CDKN2B locus in a patient presenting with Li-Fraumeni syndrome | Chan, S.H; Lim, W.K ; Michalski, S.T; Lim, J.Q; Ishak, N.D.B; Met-Domestici, M; Young, C.N.C; Vikstrom, K; Esplin, E.D; Fulbright, J; Ang, M.K ; Wee, J ; Sittampalam, K; Farid, M ; Lincoln, S.E; Itahana, K ; Abdullah, S; Teh, B.T ; Ngeow, J |
| 2016 | Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells | Itahana Y. ; Zhang J.; Göke J.; Vardy L.A.; Han R. ; Iwamoto K. ; Cukuroglu E.; Robson P.; Pouladi M.A. ; Colman A.; Itahana K. |
| 29-May-2012 | Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction | Clegg, H.V.; Itahana, Y. ; Itahana, K. ; Ramalingam, S.; Zhang, Y. |
| 1-Dec-2013 | miR-141, a new player, joins the senescence orchestra | Itahana, Y. ; Neo, S.H.; Itahana, K. |
| 1-Mar-2010 | Mitochondrial targeting signals: Another barcode in p14ARF? | Itahana, K. ; Zhang, Y. |
| 2017 | P32 heterozygosity protects against age-and diet-induced obesity by increasing energy expenditure | Liu, Y; Leslie, P.L; Jin, A; Itahana, K ; Graves, L.M; Zhang, Y |
| 15-Apr-2012 | pRb or its cousins: Who controls the family business? | Itahana, K. ; Dimri, G.P. |
| Oct-2010 | Research highlights | Itahana, K. ; Dimri, G.P. |
| 26-May-2014 | The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense | Itahana, Y. ; Han, R.; Barbier, S.; Lei, Z. ; Rozen, S. ; Itahana, K. |
| 2016 | Transglutaminase 2 contributes to a TP53- induced autophagy program to prevent oncogenic transformation | Yeo S.Y.; Itahana Y. ; Guo A.K. ; Han R. ; Iwamoto K. ; Nguyen H.T.; Bao Y. ; Kleiber K. ; Wu Y.J. ; Bay B.H. ; Voorhoeve M. ; Itahana K. |